Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Planchard

Showing results (11-20 of 243) with videos related to

Pageof 25
Sort By:
Therapeutic Advances in Medical Oncology|January 12, 2016
ALK inhibitors in non-small cell lung cancer: the latest evidence and developmentsIvana Sullivan, David Planchard
Future Oncology (London, England)|October 10, 2015
AZD9291 in EGFR-mutant advanced non-small-cell lung cancer patientsJordi Remon, David Planchard
Cancer|April 2, 2025
BRAF in non-small cell lung cancer: From molecular mechanisms to clinical practiceClaudia Parisi, David Planchard
JTO Clinical and Research Reports|June 19, 2025
Erratum to 'Targeting DLL3: A New Weapon in Lung Neuroendocrine Tumors?' [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100796]Mariona Riudavets, David Planchard
Therapeutic Advances in Respiratory Disease|October 28, 2016
Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experienceIvana Sullivan, David Planchard
Bulletin Du Cancer|November 6, 2007
[Angiogenesis targeting in lung cancers]David Planchard, Benjamin Besse
Bulletin Du Cancer|November 14, 2008
[Towards customized therapy for non small cell lung cancer]David Planchard, Benjamin Besse
Cancer Management and Research|February 7, 2018
The role of brigatinib in crizotinib-resistant non-small cell lung cancerLaura Mezquita, David Planchard
Clinical Advances in Hematology & Oncology : H&O|November 4, 2022
Ongoing progress in BRAF-mutated non-small cell lung cancerPamela Abdayem, David Planchard
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Small cell lung cancer: new clinical recommendations and current status of biomarker assessmentDavid Planchard, Cécile Le Péchoux
Pageof 25

Showing results (11-20 of 243) with videos related to

Sort By:
Pageof 25
Therapeutic Advances in Medical Oncology|January 12, 2016
ALK inhibitors in non-small cell lung cancer: the latest evidence and developmentsIvana Sullivan, David Planchard
Future Oncology (London, England)|October 10, 2015
AZD9291 in EGFR-mutant advanced non-small-cell lung cancer patientsJordi Remon, David Planchard
Cancer|April 2, 2025
BRAF in non-small cell lung cancer: From molecular mechanisms to clinical practiceClaudia Parisi, David Planchard
JTO Clinical and Research Reports|June 19, 2025
Erratum to 'Targeting DLL3: A New Weapon in Lung Neuroendocrine Tumors?' [JTO Clinical and Research Reports Volume 6 Issue 5 (2025) 100796]Mariona Riudavets, David Planchard
Therapeutic Advances in Respiratory Disease|October 28, 2016
Osimertinib in the treatment of patients with epidermal growth factor receptor T790M mutation-positive metastatic non-small cell lung cancer: clinical trial evidence and experienceIvana Sullivan, David Planchard
Bulletin Du Cancer|November 6, 2007
[Angiogenesis targeting in lung cancers]David Planchard, Benjamin Besse
Bulletin Du Cancer|November 14, 2008
[Towards customized therapy for non small cell lung cancer]David Planchard, Benjamin Besse
Cancer Management and Research|February 7, 2018
The role of brigatinib in crizotinib-resistant non-small cell lung cancerLaura Mezquita, David Planchard
Clinical Advances in Hematology & Oncology : H&O|November 4, 2022
Ongoing progress in BRAF-mutated non-small cell lung cancerPamela Abdayem, David Planchard
European Journal of Cancer (Oxford, England : 1990)|September 28, 2011
Small cell lung cancer: new clinical recommendations and current status of biomarker assessmentDavid Planchard, Cécile Le Péchoux
Pageof 25